Das L, Dutta P (2023) Approach to the patient: a case with an unusual cause of hypopituitarism. J Clin Endocrinol Metab 108(6):1488–1504
Ramiandrasoa C, Castinetti F, Raingeard I, Fenichel P, Chabre O, Brue T, Courbiere B (2013) Delayed diagnosis of Sheehan’s syndrome in a developed country: a retrospective cohort study. Eur J Endocrinol 169(4):431–438
Article CAS PubMed Google Scholar
Das L, Sahoo J, Dahiya N, Taneja S, Bhadada SK, Bhat MH, Singh P, Suri V, Laway BA, Dutta P (2022) Long-term hepatic and cardiac health in patients diagnosed with Sheehan’s syndrome. Pituitary 25(6):971–981
Article CAS PubMed Google Scholar
Laway BA, Rasool A, Baba MS, Misgar RA, Bashir MI, Wani AI, Choh N, Shah O, Lone A, Shah Z (2023) High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome-a case-control study. Clin Endocrinol (Oxf) 98(3):375–382. https://doi.org/10.1111/cen.14871
Article CAS PubMed Google Scholar
Laway BA, Ramzan M, Allai MS, Wani AI, Misgar RA (2016) Cardiac structural and functional abnormalities in females with untreated hypopituitarism due to Sheehan syndrome: response to hormone replacement therapy. Endocr Pract 22(9):1096–1103
Chihaoui M, Yazidi M, Chaker F, Belouidhnine M, Kanoun F, Lamine F, Ftouhi B, Sahli H, Slimane H (2016) Bone mineral density in Sheehan’s syndrome; prevalence of low bone mass and associated factors. J Clin Densitom 19(4):413–418
Agarwal P, Gomez R, Bhatia E, Yadav S (2019) Decreased bone mineral density in women with Sheehan’s syndrome and improvement following oestrogen replacement and nutritional supplementation. J Bone Miner Metab 25(37):171–178
Gokalp D, Tuzcu A, Bahceci M, Arikan S, Ozmen CA, Cil T (2009) Sheehan’s syndrome and its impact on bone mineral density. Gynecol Endocrinol 25(5):344–349
Article CAS PubMed Google Scholar
Ragnar Agnarsson H, Johannsson G, Ragnarsson O (2014) The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy. J Clin Endocrinol Metab 99(4):1479–1485
Ragnarsson O, Nyström HF, Johannsson G (2012) Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism. Clin Endocrinol 76(2):246–252
Zaidi M, Yuen T, Kim SM (2023) Pituitary crosstalk with bone, adipose tissue and brain. Nat Rev Endocrinol 15:1–4
Wang J, Zhang W, Yu C, Zhang X, Zhang H, Guan Q, Zhao J, Xu J (2015) Follicle-stimulating hormone increases the risk of postmenopausal osteoporosis by stimulating osteoclast differentiation. PLoS One 10(8):e0134986
Article PubMed PubMed Central Google Scholar
Seeman EH, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL (1982) Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Investig 69(6):1302–1309
Article CAS PubMed PubMed Central Google Scholar
Whittier DE, Boyd SK, Burghardt AJ, Paccou J, Ghasem-Zadeh A, Chapurlat R, Engelke K, Bouxsein ML (2020) Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos Int 31:1607–1627
Article CAS PubMed PubMed Central Google Scholar
Agarwal S, Rosete F, Zhang C, McMahon DJ, Guo XE, Shane E, Nishiyama KK (2016) In vivo assessment of bone structure and estimated bone strength by first-and second-generation HR-pQCT. Osteoporos Int 27:2955–2966
Article CAS PubMed Google Scholar
Sode M, Burghardt AJ, Pialat JB, Link TM, Majumdar S (2011) Quantitative characterization of subject motion in HR-pQCT images of the distal radius and tibia. Bone 48(6):1291–1297
Article PubMed PubMed Central Google Scholar
Mikolajewicz N, Bishop N, Burghardt AJ, Folkestad L, Hall A, Kozloff KM, Lukey PT, Molloy-Bland M, Morin SN, Offiah AC, Shapiro J (2020) HR-pQCT measures of bone microarchitecture predict fracture: systematic review and meta-analysis. J Bone Miner Res 35(3):446–459
Das L, Dutta P (2023) Unusual and lesser-known rare causes of adult growth hormone deficiency. Best Pract Res Clin Endocrinol Metab 28:101820
Kandemir N, Gone EN, Yord N (2002) Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies. J Pediatr Endocrinol Metab 15(6):809–816
Article CAS PubMed Google Scholar
Behan LA, Kelleher G, Hannon MJ, Brady JJ, Rogers B, Tormey W, Smith D, Thompson CJ, McKenna MJ, Agha A (2014) Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. Eur J Endocrinol 170(1):141–150
Article CAS PubMed Google Scholar
Ragnarsson O, Nyström HF, Johannsson G (2012) Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism. Clin Endocrinol 76(2):246–252
Hardy RS, Zhou H, Seibel MJ, Cooper MS (2018) Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy. Endocr Rev 39(5):519–548
Toogood AA, Taylor NF, Shalet SM, Monson JP (2000) Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J Clin Endocrinol Metab 85(4):1727–1730. https://doi.org/10.1210/jcem.85.4.6505
Article CAS PubMed Google Scholar
Frey KR, Kienitz T, Schulz J, Ventz M, Zopf K, Quinkler M (2018) Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency. Endocr Connect 7(6):811–818
Article CAS PubMed PubMed Central Google Scholar
Vestergaard P, Rejnmark L, Mosekilde L (2008) Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 82:249–257
Article CAS PubMed Google Scholar
Garton M, Reid I, Loveridge N, Robins S, Murchison L, Beckett G, Reid D (1994) Bone mineral density and metabolism in premenopausal women taking l-thyroxine replacement therapy. Clin Endocrinol 41(6):747–755
Sheng N, Xing F, Wang J, Duan X, Xiang Z (2023) T4 rather than TSH correlates with BMD among euthyroid adults. Front Endocrinol 9(13):1039079
de Bakker CM, Tseng WJ, Li Y, Zhao H, Liu XS (2017) Clinical evaluation of bone strength and fracture risk. Curr Osteoporos Rep 15:32–42
Riggs BL, Melton LJ III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S (2004) Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19(12):1945–1954
Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440–488
Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535–559
Article CAS PubMed PubMed Central Google Scholar
Hyldstrup L, Conway GS, Racz K, Keller A, Chanson P, Zacharin M, Lysgaard AL, Andreasen AH, Kappelgaard AM (2012) Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency. Osteoporos Int 23:2219–2226
Article CAS PubMed Google Scholar
Tanriverdi F, Unluhizarci KÜ, Kula MU, Guven M, Bayram FA, Kelestimur F (2005) Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome. Growth Hormon IGF Res 15(3):231–237
Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P, Terracina S, Prossomariti G, Boscherini B (1995) Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur J Endocrinol 132(1):42–46
Article CAS PubMed Google Scholar
Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3(Supplement 3):S131–S139
Article CAS PubMed PubMed Central Google Scholar
Cheung WH, Hung VW, Cheuk KY, Chau WW, Tsoi KK, Wong RM, Chow SK, Lam TP, Yung PS, Law SW, Qin L (2021) Best Performance parameters of HR-pQCT to predict fragility fracture: systematic review and meta-analysis. J Bone Miner Res 36(12):2381–2398
留言 (0)